Literature DB >> 22387415

Right colectomy with simultaneous vascular reconstruction for celiac and superior mesenteric arterial occlusion.

Koji Matsushita1, Shingo Tsujinaka, Yuichi Kuwahara, Yutaka J Kawamura, Fumio Konishi.   

Abstract

INTRODUCTION: Identification of the primary feeding vessel and its removal with corresponding lymphatics is crucial for oncologic bowel resection for colon cancer. However, this notion would be challenged if we encountered abnormal mesenteric vascular anatomy. We report a case of colon cancer with abnormal mesenteric circulation, for whom we performed oncologic colectomy with vascular reconstruction. PRESENTATION OF CASE: A 61-year-old man presented with obstructing transverse colon cancer. A contrast-enhanced computed tomography (CT) scan showed complete occlusion at the root of the superior mesenteric artery (SMA) and the celiac artery (CA), with evidently dilated marginal artery (MA). An X-ray angiography revealed retrograde arterial blood flow originating from the inferior mesenteric artery (IMA) via the MA, the SMA, and to the CA. At laparotomy, we found remarkably dilated MA with the mid-transverse colon cancer. There were no other communicating vessels between the IMA and the SMA. Right colectomy with proper lymph node dissection was completed, following vascular anastomosis between the MA to the SMA. His postoperative course was uneventful. A postoperative CT angiography showed revascularization of the areas where the SMA and the CA supplied. DISCUSSION: In this patient, if the abberant mesenteric circulation remained unrecognized at the time of surgery, and the MA were divided without vascular reconstruction, severe ischemia and subsequent gangrene of large part of the visceral organs would have occurred.
CONCLUSION: This case illustrates the fundamental importance of assessment for vascular anatomy in patients undergoing oncologic abdominal surgery which associates with division of major mesenteric arteries.
Copyright © 2012 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Year:  2012        PMID: 22387415      PMCID: PMC3316766          DOI: 10.1016/j.ijscr.2012.01.010

Source DB:  PubMed          Journal:  Int J Surg Case Rep        ISSN: 2210-2612


  7 in total

Review 1.  Mesenteric ischemia: the whole spectrum.

Authors:  M J Sise
Journal:  Scand J Surg       Date:  2010       Impact factor: 2.360

2.  Practice parameters for colon cancer.

Authors:  Daniel Otchy; Neil H Hyman; Clifford Simmang; Thomas Anthony; W Donald Buie; Peter Cataldo; James Church; Jeffrey Cohen; Frederick Dentsman; C Neal Ellis; John W Kilkenny; Clifford Ko; Richard Moore; Charles Orsay; Ronald Place; Janice Rafferty; Jan Rakinic; Paul Savoca; Joe Tjandra; Mark Whiteford
Journal:  Dis Colon Rectum       Date:  2004-08       Impact factor: 4.585

3.  Clinical utility and cost-effectiveness of routine preoperative computed tomography scanning in patients with colon cancer.

Authors:  David C Mauchley; Dana C Lynge; Lorrie A Langdale; Matthias G Stelzner; Charles N Mock; Kevin G Billingsley
Journal:  Am J Surg       Date:  2005-05       Impact factor: 2.565

Review 4.  The meandering mesenteric artery: a historic review and surgical implications.

Authors:  Eric J Gourley; Scott A Gering
Journal:  Dis Colon Rectum       Date:  2005-05       Impact factor: 4.585

5.  The meandering mesenteric artery or central anastomotic artery.

Authors:  John E Connolly
Journal:  J Vasc Surg       Date:  2006-05       Impact factor: 4.268

Review 6.  Riolan's arch: confusing, misnomer, and obsolete. A literature survey of the connection(s) between the superior and inferior mesenteric arteries.

Authors:  Johan F Lange; Niels Komen; Germaine Akkerman; Erik Nout; Herman Horstmanshoff; Frans Schlesinger; Jaap Bonjer; Gerrit-Jan Kleinrensink
Journal:  Am J Surg       Date:  2007-06       Impact factor: 2.565

Review 7.  Chronic gastrointestinal ischaemia: shifting paradigms.

Authors:  Peter B F Mensink; Leon M G Moons; Ernst J Kuipers
Journal:  Gut       Date:  2010-11-29       Impact factor: 23.059

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.